Why autoimmune diseases mostly strike women and are often misdiagnosed - Top-Institutions - MDSpire

Why autoimmune diseases mostly strike women and are often misdiagnosed

  • By

  • Lauran Neergaard

  • November 6, 2025

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Autoimmune Diseases
    • Immunology
    • Rheumatology
    • Neurology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Autoimmune Diseases
    • Rheumatology
    • Immunology
    • Neurology

  • #3

    National Institute of Allergy and Infectious Diseases (NIAID), NIH
    National Institute of Allergy and Infectious Diseases (NIAID), NIH

    Bethesda, MD

    Key Differentiators

    • Immunology
    • Autoimmune Disease Research
    • Clinical Trials

  • #4

    NYU Langone Health
    NYU Langone Health

    New York, NY

    Key Differentiators

    • Rheumatology
    • Immunology
    • Autoimmune Diseases

  • #5

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Autoimmune Diseases
    • Immunology
    • Rheumatology

Original Source(s)

Why autoimmune diseases mostly strike women and are often misdiagnosed

  • by Lauran Neergaard

  • November 6, 2025

Related Content

Roswell Park Offering CAR T Trial for Autoimmune Conditions

While most CAR T-cell therapies and clinical trials are directed at cancers, a new phase 1 trial at Roswell Park Comprehensive Cancer Center is open and recruiting patients with a variety of autoimmune conditions.

  • December 12, 2025

  • 1 min
Connective tissue diseases combined with chronic myelomonocytic leukemia and myelofibrosis: a case report and literature review

UCI Health lupus clinical trial offers hope to patients with the disease

Patient experinces life-changing improvements thanks to CAR T-cell therapy.

  • by

  • April 8, 2026

  • 1 min